Email this article 
THE SAFETY AND TOLERABILITY OF SORAFENIB IN THE TREATMENT OF EXTENSIVE RENAL CANCER
- Authors: Biryukov V.A.1, Karyakin O.B.1
-
Affiliations:
- Medical Radiology Research Center, Obninsk
- Issue: Vol 5, No 1 (2009)
- Pages: 19-26
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS
- Published: 30.03.2009
- URL: https://oncourology.abvpress.ru/oncur/article/view/179
- DOI: https://doi.org/10.17650/1726-9776-2009-5-1-19-26
- ID: 179
Cite item
Full Text
Abstract
The performed study compared the toxic effects caused by the administration of sorafenib with the manifestations that immediately accompanied extensive renal-cell carcinoma. There is evidence that Sorafenib that is a safe and well tolerable agent increases progression-freesurvival.
About the authors
V. A. Biryukov
Medical Radiology Research Center, Obninsk
Author for correspondence.
Russian Federation
O. B. Karyakin
Medical Radiology Research Center, ObninskRussian Federation
References
Supplementary files
